CELL ORIGIN
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors 2023-12-21 01:00
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy 2022-09-26 12:31
CellOrigin Closed a New Round of Investment to Jump-start its iPSC Immune Cell Therapy Products Toward Clinics 2022-03-29 20:50
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform 2021-10-15 20:50
1